LFVN Lifevantage Corp

Price (delayed)

$7.4

Market cap

$103.64M

P/E Ratio

8.92

Dividend/share

N/A

EPS

$0.83

Enterprise value

$102.51M

LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced ...

Highlights
The price to earnings (P/E) is 63% less than the 5-year quarterly average of 24.0 and 32% less than the last 4 quarters average of 13.2
LFVN's quick ratio has surged by 59% year-on-year
The debt has grown by 2.2% from the previous quarter
LFVN's gross profit is down by 2.4% YoY and by 2.2% QoQ

Key stats

What are the main financial stats of LFVN
Market
Shares outstanding
14M
Market cap
$103.64M
Enterprise value
$102.51M
Valuations
Price to earnings (P/E)
8.92
Price to book (P/B)
2.94
Price to sales (P/S)
0.46
EV/EBIT
6.08
EV/EBITDA
4.43
EV/Sales
0.46
Earnings
Revenue
$224.77M
EBIT
$16.86M
EBITDA
$23.14M
Free cash flow
$13.41M
Per share
EPS
$0.83
Free cash flow per share
$0.95
Book value per share
$2.51
Revenue per share
$15.97
TBVPS
$5.29
Balance sheet
Total assets
$75.12M
Total liabilities
$39.49M
Debt
$17.83M
Equity
$35.63M
Working capital
$21.34M
Liquidity
Debt to equity
0.5
Current ratio
1.96
Quick ratio
1
Net debt/EBITDA
-0.05
Margins
EBITDA margin
10.3%
Gross margin
83.2%
Net margin
5.3%
Operating margin
7.7%
Efficiency
Return on assets
17%
Return on equity
34.1%
Return on invested capital
43%
Return on capital employed
31.9%
Return on sales
7.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFVN stock price

How has the Lifevantage stock price performed over time
Intraday
-3.39%
1 week
-13.15%
1 month
-8.75%
1 year
-46.49%
YTD
-20.6%
QTD
-20.86%

Financial performance

How have Lifevantage's revenue and profit performed over time
Revenue
$224.77M
Gross profit
$186.92M
Operating income
$17.24M
Net income
$11.81M
Gross margin
83.2%
Net margin
5.3%
The company's operating margin rose by 18% YoY but it fell by 2.5% QoQ
LFVN's operating income is up by 16% year-on-year but it is down by 5% since the previous quarter
The net margin has grown by 3.9% from the previous quarter and by 3.9% YoY
LFVN's gross profit is down by 2.4% YoY and by 2.2% QoQ

Growth

What is Lifevantage's growth rate over time

Valuation

What is Lifevantage stock price valuation
P/E
8.92
P/B
2.94
P/S
0.46
EV/EBIT
6.08
EV/EBITDA
4.43
EV/Sales
0.46
The price to earnings (P/E) is 63% less than the 5-year quarterly average of 24.0 and 32% less than the last 4 quarters average of 13.2
The price to book (P/B) is 54% lower than the 5-year quarterly average of 6.4 and 36% lower than the last 4 quarters average of 4.6
The company's equity rose by 25% YoY
The P/S is 34% less than the last 4 quarters average of 0.7 and 23% less than the 5-year quarterly average of 0.6
The revenue has declined by 2.2% year-on-year

Efficiency

How efficient is Lifevantage business performance
The return on invested capital has dropped by 50% year-on-year and by 26% since the previous quarter
LFVN's ROS is up by 21% YoY but it is down by 2.6% QoQ
The company's return on assets fell by 20% YoY and by 8% QoQ
LFVN's return on equity is down by 16% year-on-year and by 4.5% since the previous quarter

Dividends

What is LFVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFVN.

Financial health

How did Lifevantage financials performed over time
Lifevantage's total assets is 90% more than its total liabilities
The company's total liabilities has surged by 66% YoY
LFVN's quick ratio has surged by 59% year-on-year
The debt is 50% less than the equity
The company's equity rose by 25% YoY
The debt has grown by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.